In colorectal cancer, n‐3 FAs have been shown to reduce VEGF expression by inhibiting the COX‐2/PGE2 pathway, leading to the suppression of ERK1/2, a crucial component of VEGF synthesis [33, 34]. Here, VEGFA is linked to colorectal cancer.